• Profile
Close

Secondary prevention after stroke/transient ischemic attack, a randomized audit&feedback trial

Acta Neurologica Scandinavica Apr 27, 2019

Geary L, et al. - Via conducting a randomized audit&feedback trial, researchers sought to improve the use of secondary preventive stroke drugs and diagnosis recording in ischemic stroke/TIA. In the 18 months following the intervention, medication dispensation for statins, antihypertensives, antiplatelets and anticoagulants, as well as recording of diagnosis, was compared between intervention centers and control centers. There were no differences in the dispensation of medication between intervention and control centers after the intervention, even after adjustment for potential confounders. A simple audit&feedback intervention aimed at primary care doctors did not improve the dispensation of medication to patients with ischemic stroke/TIA 18 months later. Any future audit&feedback intervention aimed at enhancing adherence to guidelines for secondary prevention in primary care should take into account multiple and continuous reminders, the graphic appeal, and expanding recipients to include patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay